Abstract
Background: Cytoreductive surgery (CRS) and hepatectomy are accepted surgical strategies to manage metastatic disease in colorectal cancer(CRC).The safety and outcomes of patients undergoing both operative treatment to manage abdominal oligometastatic disease from CRC is less well established.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
